Affinity DataKi: 0.600nMAssay Description:Inhibition of HIV-1 protease using Abz-NF-6 as substrate assessed as inhibition constant measured every 2 mins for 20 mins by fluorescence based ELIS...More data for this Ligand-Target Pair
Ligand Info
Affinity DataKi: 1.5nMAssay Description:Inhibition of HIV-1 protease using Abz-NF-6 as substrate assessed as inhibition constant measured every 2 mins for 20 mins by fluorescence based ELIS...More data for this Ligand-Target Pair
Ligand Info
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Affinity DataKi: 2.10nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Affinity DataKi: 2.10nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Affinity DataKi: 2.5nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Affinity DataKi: 2.60nMAssay Description:Inhibition of [3H]-SKF- 107260 binding to purified GPIIb/IIIa from human platelets reconstituted in liposomesMore data for this Ligand-Target Pair
Affinity DataKi: 4.40nMAssay Description:Inhibition of HIV-1 protease using Abz-NF-6 as substrate assessed as inhibition constant measured every 2 mins for 20 mins by fluorescence based ELIS...More data for this Ligand-Target Pair
Ligand InfoPDB
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Affinity DataKi: 4.80nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
Affinity DataKi: 5nMAssay Description:Binding affinity against alpha-2-adrenergic receptor using 10 nM [3H]yohimbine in human platelet membranes from three separate experiments using 10 i...More data for this Ligand-Target Pair
Affinity DataKi: 5.30nMAssay Description:Inhibition of HIV-1 protease using Abz-NF-6 as substrate assessed as inhibition constant measured every 2 mins for 20 mins by fluorescence based ELIS...More data for this Ligand-Target Pair
Ligand Info
Affinity DataKi: 6.10nMAssay Description:Binding affinity against alpha-2-adrenergic receptor using 10 nM [3H]yohimbine in human platelet membranes from three separate experiments using 10 i...More data for this Ligand-Target Pair
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Affinity DataKi: 8.5nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
Affinity DataKi: 8.90nMAssay Description:Inhibition of HIV-1 protease using Abz-NF-6 as substrate assessed as inhibition constant measured every 2 mins for 20 mins by fluorescence based ELIS...More data for this Ligand-Target Pair
Ligand InfoPDB
Affinity DataKi: 9.10nMAssay Description:Inhibition of HIV-1 protease using Abz-NF-6 as substrate assessed as inhibition constant measured every 2 mins for 20 mins by fluorescence based ELIS...More data for this Ligand-Target Pair
Ligand Info
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Affinity DataKi: 9.30nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Affinity DataKi: 9.5nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
Affinity DataKi: 13nMAssay Description:Inhibition of HIV-1 protease using Abz-NF-6 as substrate assessed as inhibition constant measured every 2 mins for 20 mins by fluorescence based ELIS...More data for this Ligand-Target Pair
Ligand InfoPDB
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Affinity DataKi: 13.7nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
Affinity DataKi: 16nMAssay Description:Inhibition of HIV-1 protease using Abz-NF-6 as substrate assessed as inhibition constant measured every 2 mins for 20 mins by fluorescence based ELIS...More data for this Ligand-Target Pair
Affinity DataKi: 17nMAssay Description:Binding affinity against alpha-2-adrenergic receptor using 10 nM [3H]yohimbine in human platelet membranes from three separate experiments using 10 i...More data for this Ligand-Target Pair
Affinity DataKi: 18nMAssay Description:IC50 values were determined for compounds that covalently inhibit SARS-CoV-2 3CLpro using our recently described assay and data fitting methods that ...More data for this Ligand-Target Pair
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Affinity DataKi: 20nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Affinity DataKi: 20nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Affinity DataKi: 24.3nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Affinity DataKi: 24.5nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Affinity DataKi: 26nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Affinity DataKi: 26nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Affinity DataKi: 27nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Affinity DataKi: 35nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Affinity DataKi: 45nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
Affinity DataKi: 48nMAssay Description:Binding affinity against alpha-2-adrenergic receptor using 10 nM [3H]yohimbine in human platelet membranes from four to five separate experiments usi...More data for this Ligand-Target Pair
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Affinity DataKi: 58nMAssay Description:Inhibition of [3H]-SKF- 107260 binding to purified GPIIb/IIIa from human platelets reconstituted in liposomesMore data for this Ligand-Target Pair
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Affinity DataKi: 58nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Affinity DataKi: 65nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Affinity DataKi: 77nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Affinity DataKi: 82nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
Affinity DataKi: 92nMAssay Description:Inhibition of HIV-1 protease using Abz-NF-6 as substrate assessed as inhibition constant measured every 2 mins for 20 mins by fluorescence based ELIS...More data for this Ligand-Target Pair
Ligand Info
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Affinity DataKi: 110nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Affinity DataKi: 125nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Affinity DataKi: 135nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Affinity DataKi: 143nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Affinity DataKi: 188nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
Affinity DataKi: 232nMAssay Description:Binding affinity against alpha-2-adrenergic receptor using 10 nM [3H]yohimbine in preparations in human platelet membranes from three separate experi...More data for this Ligand-Target Pair
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Affinity DataKi: 280nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
Affinity DataKi: 302nMAssay Description:Inhibition of HIV-1 protease using Abz-NF-6 as substrate assessed as inhibition constant measured every 2 mins for 20 mins by fluorescence based ELIS...More data for this Ligand-Target Pair
Ligand Info
Affinity DataKi: 338nMAssay Description:Binding affinity against alpha-2-adrenergic receptor using 10 nM [3H]yohimbine in human platelet membranes from three separate experiments using 10 i...More data for this Ligand-Target Pair
Affinity DataKi: 388nMAssay Description:Inhibition of HIV-1 protease using Abz-NF-6 as substrate assessed as inhibition constant measured every 2 mins for 20 mins by fluorescence based ELIS...More data for this Ligand-Target Pair
Ligand Info
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Affinity DataKi: 430nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
Affinity DataKi: 445nMAssay Description:Inhibition of HIV-1 protease using Abz-NF-6 as substrate assessed as inhibition constant measured every 2 mins for 20 mins by fluorescence based ELIS...More data for this Ligand-Target Pair
Ligand Info
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Affinity DataKi: 610nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair